IL10 and type 1 diabetes mellitus: Lactobacillus kefiranofaciens M and lactobacillus kefiri K were reported to mitigate progression of type 1 diabetes through inhibiting pro-inflammatory and inflammatory cytokines and elevating the production of IL-10.